APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biothrax (Anthrax Vaccine)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Biothrax (Anthrax Vaccine) Industry Research Report 2026

Report ID 17397102052 January 2026142 pages

Choose your research edition.

Industry ResearchBiothrax (Anthrax Vaccine) Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Biothrax (Anthrax Vaccine) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Biothrax (Anthrax Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biothrax (Anthrax Vaccine) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Biothrax (Anthrax Vaccine) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Biothrax (Anthrax Vaccine) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Biothrax (Anthrax Vaccine) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Biothrax (Anthrax Vaccine) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Biothrax (Anthrax Vaccine) include Merck, Tiankang, Zoetis, Vecol, Rosenbusch, Prondil, PharmAthene, Merial and JOVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Biothrax (Anthrax Vaccine) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biothrax (Anthrax Vaccine) Market by Company

Merck

Tiankang

Zoetis

Vecol

Rosenbusch

Prondil

PharmAthene

Merial

JOVAC

IVPM

Intervac

Indian Immunologicals

CVCRI

Colorado Serum

Ceva Santé Animale

CDV

CAVAC

Botswana Vaccine Institute

Biogénesis-Bago

Bayer Sanidad Animal

Agrovet

Biothrax (Anthrax Vaccine) Segment by Type

Live Vaccines

Cell Free PA Vaccines

Biothrax (Anthrax Vaccine) Segment by Application

Human Use

Animal Use

Biothrax (Anthrax Vaccine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biothrax (Anthrax Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biothrax (Anthrax Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biothrax (Anthrax Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Biothrax (Anthrax Vaccine) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Biothrax (Anthrax Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biothrax (Anthrax Vaccine) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Biothrax (Anthrax Vaccine) Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Biothrax (Anthrax Vaccine) Revenue of Manufacturers (2021-2026) Table 9. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Biothrax (Anthrax Vaccine) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application Table 14. Global Biothrax (Anthrax Vaccine) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Biothrax (Anthrax Vaccine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Merck Biothrax (Anthrax Vaccine) Product Portfolio Table 22. Merck Recent Developments Table 23. Tiankang Company Information Table 24. Tiankang Business Overview Table 25. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Tiankang Biothrax (Anthrax Vaccine) Product Portfolio Table 27. Tiankang Recent Developments Table 28. Zoetis Company Information Table 29. Zoetis Business Overview Table 30. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Zoetis Biothrax (Anthrax Vaccine) Product Portfolio Table 32. Zoetis Recent Developments Table 33. Vecol Company Information Table 34. Vecol Business Overview Table 35. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Vecol Biothrax (Anthrax Vaccine) Product Portfolio Table 37. Vecol Recent Developments Table 38. Rosenbusch Company Information Table 39. Rosenbusch Business Overview Table 40. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio Table 42. Rosenbusch Recent Developments Table 43. Prondil Company Information Table 44. Prondil Business Overview Table 45. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Prondil Biothrax (Anthrax Vaccine) Product Portfolio Table 47. Prondil Recent Developments Table 48. PharmAthene Company Information Table 49. PharmAthene Business Overview Table 50. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio Table 52. PharmAthene Recent Developments Table 53. Merial Company Information Table 54. Merial Business Overview Table 55. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Merial Biothrax (Anthrax Vaccine) Product Portfolio Table 57. Merial Recent Developments Table 58. JOVAC Company Information Table 59. JOVAC Business Overview Table 60. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. JOVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 62. JOVAC Recent Developments Table 63. IVPM Company Information Table 64. IVPM Business Overview Table 65. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. IVPM Biothrax (Anthrax Vaccine) Product Portfolio Table 67. IVPM Recent Developments Table 68. Intervac Company Information Table 69. Intervac Business Overview Table 70. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Intervac Biothrax (Anthrax Vaccine) Product Portfolio Table 72. Intervac Recent Developments Table 73. Indian Immunologicals Company Information Table 74. Indian Immunologicals Business Overview Table 75. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio Table 77. Indian Immunologicals Recent Developments Table 78. CVCRI Company Information Table 79. CVCRI Business Overview Table 80. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CVCRI Biothrax (Anthrax Vaccine) Product Portfolio Table 82. CVCRI Recent Developments Table 83. Colorado Serum Company Information Table 84. Colorado Serum Business Overview Table 85. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio Table 87. Colorado Serum Recent Developments Table 88. Ceva Santé Animale Company Information Table 89. Ceva Santé Animale Business Overview Table 90. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio Table 92. Ceva Santé Animale Recent Developments Table 93. CDV Company Information Table 94. CDV Business Overview Table 95. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. CDV Biothrax (Anthrax Vaccine) Product Portfolio Table 97. CDV Recent Developments Table 98. CAVAC Company Information Table 99. CAVAC Business Overview Table 100. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CAVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 102. CAVAC Recent Developments Table 103. Botswana Vaccine Institute Company Information Table 104. Botswana Vaccine Institute Business Overview Table 105. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio Table 107. Botswana Vaccine Institute Recent Developments Table 108. Biogénesis-Bago Company Information Table 109. Biogénesis-Bago Business Overview Table 110. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio Table 112. Biogénesis-Bago Recent Developments Table 113. Bayer Sanidad Animal Company Information Table 114. Bayer Sanidad Animal Business Overview Table 115. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio Table 117. Bayer Sanidad Animal Recent Developments Table 118. Agrovet Company Information Table 119. Agrovet Business Overview Table 120. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Agrovet Biothrax (Anthrax Vaccine) Product Portfolio Table 122. Agrovet Recent Developments Table 123. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units) Table 125. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2021-2026) Table 126. Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032) & (K Units) Table 127. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2027-2032) Table 128. Global Biothrax (Anthrax Vaccine) Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2021-2026) Table 130. Global Biothrax (Anthrax Vaccine) Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2027-2032) Table 132. North America Biothrax (Anthrax Vaccine) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 134. North America Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 135. North America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Biothrax (Anthrax Vaccine) Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Biothrax (Anthrax Vaccine) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 139. Europe Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 140. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Biothrax (Anthrax Vaccine) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 149. South America Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 150. South America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Biothrax (Anthrax Vaccine) Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 158. Global Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 159. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2026) Table 160. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2027-2032) Table 161. Global Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2026) Table 164. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2027-2032) Table 165. Global Biothrax (Anthrax Vaccine) Price by Type (2021-2026) & (US$/Unit) Table 166. Global Biothrax (Anthrax Vaccine) Price by Type (2027-2032) & (US$/Unit) Table 167. Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 168. Global Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 169. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2026) Table 170. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2027-2032) Table 171. Global Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2026) Table 174. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2027-2032) Table 175. Global Biothrax (Anthrax Vaccine) Price by Application (2021-2026) & (US$/Unit) Table 176. Global Biothrax (Anthrax Vaccine) Price by Application (2027-2032) & (US$/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Biothrax (Anthrax Vaccine) Distributors List Table 180. Biothrax (Anthrax Vaccine) Customers List Table 181. Biothrax (Anthrax Vaccine) Industry Trends Table 182. Biothrax (Anthrax Vaccine) Industry Drivers Table 183. Biothrax (Anthrax Vaccine) Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biothrax (Anthrax Vaccine) Product Image Figure 5. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Biothrax (Anthrax Vaccine) Market Size (2021-2032) & (US$ Million) Figure 7. Global Biothrax (Anthrax Vaccine) Sales (2021-2032) & (K Units) Figure 8. Global Biothrax (Anthrax Vaccine) Average Price (US$/Unit) & (2021-2032) Figure 9. Live Vaccines Product Image Figure 10. Cell Free PA Vaccines Product Image Figure 11. Human Use Product Image Figure 12. Animal Use Product Image Figure 13. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Biothrax (Anthrax Vaccine) Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Biothrax (Anthrax Vaccine) Sales by Region in 2025 Figure 19. Global Biothrax (Anthrax Vaccine) Revenue by Region in 2025 Figure 20. North America Biothrax (Anthrax Vaccine) Market Size by Country in 2025 Figure 21. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2032) Figure 22. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2021-2032) Figure 23. United States Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Biothrax (Anthrax Vaccine) Market Size by Country in 2025 Figure 26. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2032) Figure 27. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2021-2032) Figure 28. Germany Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Country in 2025 Figure 34. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2021-2032) Figure 36. China Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Biothrax (Anthrax Vaccine) Market Size by Country in 2025 Figure 45. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2032) Figure 46. South America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2021-2032) Figure 47. Mexico Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Colombia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country in 2025 Figure 52. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2021-2032) Figure 54. Turkey Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Biothrax (Anthrax Vaccine) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2032) Figure 58. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2032) Figure 59. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2021-2032) Figure 60. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2032) Figure 61. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2032) Figure 62. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2021-2032) Figure 63. Biothrax (Anthrax Vaccine) Value Chain Figure 64. Biothrax (Anthrax Vaccine) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live Vaccines
  • Cell Free PA Vaccines
Applications
  • Human Use
  • Animal Use
Companies covered
  • Merck
  • Tiankang
  • Zoetis
  • Vecol
  • Rosenbusch
  • Prondil
  • PharmAthene
  • Merial
  • JOVAC
  • IVPM
  • Intervac
  • Indian Immunologicals
  • CVCRI
  • Colorado Serum
  • Ceva Santé Animale
  • CDV
  • CAVAC
  • Botswana Vaccine Institute
  • Biogénesis-Bago
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Biothrax (Anthrax Vaccine) Market Size (2021-2032)
  4. 2.2.2 Global Biothrax (Anthrax Vaccine) Sales (2021-2032)
  5. 2.2.3 Global Biothrax (Anthrax Vaccine) Market Average Price (2021-2032)
  6. 2.3 Biothrax (Anthrax Vaccine) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live Vaccines
  9. 2.3.3 Cell Free PA Vaccines
  10. 2.4 Biothrax (Anthrax Vaccine) by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Human Use
  13. 2.4.3 Animal Use
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biothrax (Anthrax Vaccine) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Biothrax (Anthrax Vaccine) Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Biothrax (Anthrax Vaccine) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Biothrax (Anthrax Vaccine) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application
  8. 3.8 Global Manufacturers of Biothrax (Anthrax Vaccine), Established Date
  9. 3.9 Global Biothrax (Anthrax Vaccine) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Tiankang
  8. 4.2.1 Tiankang Company Information
  9. 4.2.2 Tiankang Business Overview
  10. 4.2.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
  12. 4.2.5 Tiankang Recent Developments
  13. 4.3 Zoetis
  14. 4.3.1 Zoetis Company Information
  15. 4.3.2 Zoetis Business Overview
  16. 4.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
  18. 4.3.5 Zoetis Recent Developments
  19. 4.4 Vecol
  20. 4.4.1 Vecol Company Information
  21. 4.4.2 Vecol Business Overview
  22. 4.4.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
  24. 4.4.5 Vecol Recent Developments
  25. 4.5 Rosenbusch
  26. 4.5.1 Rosenbusch Company Information
  27. 4.5.2 Rosenbusch Business Overview
  28. 4.5.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
  30. 4.5.5 Rosenbusch Recent Developments
  31. 4.6 Prondil
  32. 4.6.1 Prondil Company Information
  33. 4.6.2 Prondil Business Overview
  34. 4.6.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
  36. 4.6.5 Prondil Recent Developments
  37. 4.7 PharmAthene
  38. 4.7.1 PharmAthene Company Information
  39. 4.7.2 PharmAthene Business Overview
  40. 4.7.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
  42. 4.7.5 PharmAthene Recent Developments
  43. 4.8 Merial
  44. 4.8.1 Merial Company Information
  45. 4.8.2 Merial Business Overview
  46. 4.8.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
  48. 4.8.5 Merial Recent Developments
  49. 4.9 JOVAC
  50. 4.9.1 JOVAC Company Information
  51. 4.9.2 JOVAC Business Overview
  52. 4.9.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
  54. 4.9.5 JOVAC Recent Developments
  55. 4.10 IVPM
  56. 4.10.1 IVPM Company Information
  57. 4.10.2 IVPM Business Overview
  58. 4.10.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
  60. 4.10.5 IVPM Recent Developments
  61. 4.11 Intervac
  62. 4.11.1 Intervac Company Information
  63. 4.11.2 Intervac Business Overview
  64. 4.11.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
  66. 4.11.5 Intervac Recent Developments
  67. 4.12 Indian Immunologicals
  68. 4.12.1 Indian Immunologicals Company Information
  69. 4.12.2 Indian Immunologicals Business Overview
  70. 4.12.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
  72. 4.12.5 Indian Immunologicals Recent Developments
  73. 4.13 CVCRI
  74. 4.13.1 CVCRI Company Information
  75. 4.13.2 CVCRI Business Overview
  76. 4.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
  78. 4.13.5 CVCRI Recent Developments
  79. 4.14 Colorado Serum
  80. 4.14.1 Colorado Serum Company Information
  81. 4.14.2 Colorado Serum Business Overview
  82. 4.14.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
  84. 4.14.5 Colorado Serum Recent Developments
  85. 4.15 Ceva Santé Animale
  86. 4.15.1 Ceva Santé Animale Company Information
  87. 4.15.2 Ceva Santé Animale Business Overview
  88. 4.15.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
  90. 4.15.5 Ceva Santé Animale Recent Developments
  91. 4.16 CDV
  92. 4.16.1 CDV Company Information
  93. 4.16.2 CDV Business Overview
  94. 4.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
  96. 4.16.5 CDV Recent Developments
  97. 4.17 CAVAC
  98. 4.17.1 CAVAC Company Information
  99. 4.17.2 CAVAC Business Overview
  100. 4.17.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
  102. 4.17.5 CAVAC Recent Developments
  103. 4.18 Botswana Vaccine Institute
  104. 4.18.1 Botswana Vaccine Institute Company Information
  105. 4.18.2 Botswana Vaccine Institute Business Overview
  106. 4.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
  108. 4.18.5 Botswana Vaccine Institute Recent Developments
  109. 4.19 Biogénesis-Bago
  110. 4.19.1 Biogénesis-Bago Company Information
  111. 4.19.2 Biogénesis-Bago Business Overview
  112. 4.19.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
  114. 4.19.5 Biogénesis-Bago Recent Developments
  115. 4.20 Bayer Sanidad Animal
  116. 4.20.1 Bayer Sanidad Animal Company Information
  117. 4.20.2 Bayer Sanidad Animal Business Overview
  118. 4.20.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
  120. 4.20.5 Bayer Sanidad Animal Recent Developments
  121. 4.21 Agrovet
  122. 4.21.1 Agrovet Company Information
  123. 4.21.2 Agrovet Business Overview
  124. 4.21.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
  126. 4.21.5 Agrovet Recent Developments
5 Global Biothrax (Anthrax Vaccine) Market Scenario by Region
  1. 5.1 Global Biothrax (Anthrax Vaccine) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biothrax (Anthrax Vaccine) Sales by Region: 2021-2032
  3. 5.2.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2021-2026
  4. 5.2.2 Global Biothrax (Anthrax Vaccine) Sales by Region: 2027-2032
  5. 5.3 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2021-2032
  6. 5.3.1 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2021-2026
  7. 5.3.2 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2027-2032
  8. 5.4 North America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
  9. 5.4.1 North America Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  11. 5.4.3 North America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
  15. 5.5.1 Europe Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  17. 5.5.3 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
  35. 5.7.1 South America Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  37. 5.7.3 South America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  2. 6.1.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  5. 6.2.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  2. 7.1.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  5. 7.2.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Biothrax (Anthrax Vaccine) Value Chain Analysis
  2. 8.1.1 Biothrax (Anthrax Vaccine) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Biothrax (Anthrax Vaccine) Production Mode & Process
  5. 8.2 Biothrax (Anthrax Vaccine) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Biothrax (Anthrax Vaccine) Distributors
  8. 8.2.3 Biothrax (Anthrax Vaccine) Customers
9 Global Biothrax (Anthrax Vaccine) Analyzing Market Dynamics
  1. 9.1 Biothrax (Anthrax Vaccine) Industry Trends
  2. 9.2 Biothrax (Anthrax Vaccine) Industry Drivers
  3. 9.3 Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges
  4. 9.4 Biothrax (Anthrax Vaccine) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst